8-K: cbdMD Submits Plan to Regain NYSE American Listing Compliance

cbdMD, Inc. has submitted a plan to the NYSE American to regain compliance with continued listing standards after receiving a non-compliance notice.

Summary

• cbdMD, Inc. received a notification from the NYSE American on June 5, 2024, stating that the company was no longer in compliance with continued listing standards.
• The company was required to submit a plan by July 5, 2024, outlining how it intends to regain compliance by December 5, 2025.
• cbdMD submitted its plan to the NYSE American on July 5, 2024.
• The company expects to receive a response from the NYSE American in August 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the company is addressing a negative situation (non-compliance) with a required action (submitting a plan). The outcome is still uncertain.

Positives

• cbdMD has taken timely action by submitting the required compliance plan by the deadline.
• The company has a clear timeline to regain compliance by December 5, 2025.

Negatives

• The company is currently not in compliance with NYSE American's continued listing standards.
• There is uncertainty regarding whether the NYSE American will accept the company's plan.

Risks

• There is a risk that the NYSE American may not accept the company's plan.
• Failure to regain compliance could lead to delisting from the NYSE American.

Future Outlook

The company expects to receive a response from NYSE American in August 2024 regarding its compliance plan.

Management Comments

• The company is taking actions to regain compliance with the continued listing standards.

Industry Context

This announcement is specific to cbdMD's listing status and does not directly reflect broader industry trends, but it highlights the importance of maintaining compliance with exchange listing requirements.

Comparison to Industry Standards

• Many companies face challenges in maintaining listing compliance, especially during periods of financial difficulty or market volatility.
• Other companies that have faced similar issues include those in the biotech and small-cap sectors, where financial performance can be volatile.
• The specific requirements for listing compliance vary by exchange, but generally involve minimum share price, market capitalization, and financial performance metrics.

Stakeholder Impact

• Shareholders are impacted by the uncertainty surrounding the company's listing status.
• Employees may be concerned about the company's future if delisting occurs.
• Customers and suppliers may be indirectly affected by the company's financial stability.

Next Steps

• The company will await a response from the NYSE American in August 2024.
• The company will need to execute its plan to regain compliance by December 5, 2025.

Key Dates

Keywords

NYSE American, listing compliance, non-compliance, compliance plan, delisting, cbdMD